Novartis to present Gilenya data at neurology conference
ZURICH, March 13
ZURICH, March 13 (Reuters) - Novartis said data on multiple sclerosis drug Gilenya will be presented at an upcoming neurology conference.
Three late-stage clinical studies on the drug will be presented to the American Academy of Neurology American Academy of Neurology, which takes place March 16 to 23. (Reporting By Katharina Bart)